Jašarević, Eldin
Hecht, Patrick M.
Fritsche, Kevin L.
Geary, David C.
Rivera, Rocío M.
Beversdorf, David Q. http://orcid.org/0000-0002-0298-0634
Article History
Received: 10 August 2020
Accepted: 26 December 2020
First Online: 9 January 2021
Ethics approval and consent to participate
: All experiments were approved by the University of Missouri-Columbia Institutional Animal Care and Use Committee and performed in accordance with the National Institutes of Health Animal Care and Use Guidelines.
: Not applicable.
: Dr. Beversdorf has consulted with Quadrant Biosciences, Impel Pharma, YAMO Pharma, and Stalicla, unrelated to this work, and was not a consultant at the time of this work. Dr. Hecht is now an employee of AbbVie, unrelated to this work, and was not employed by them at the time of this work. The remaining authors declare that they have no competing interests.